{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:38:18Z","timestamp":1783078698464,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 22203057"],"award-info":[{"award-number":["No. 22203057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint project of Luzhou Municipal People\u2019s Government and Southwest Medical University","award":["2020LZXNYDJ39"],"award-info":[{"award-number":["2020LZXNYDJ39"]}]},{"name":"Research and Development Fund Project of Sichuan North Medical College","award":["CBY22-QNA38"],"award-info":[{"award-number":["CBY22-QNA38"]}]},{"name":"Research and Development Fund Project of Sichuan North Medical College","award":["CBY22-QNA18"],"award-info":[{"award-number":["CBY22-QNA18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05686-2","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:19:19Z","timestamp":1724397559000},"page":"1941-1958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5873-4576","authenticated-orcid":false,"given":"Qiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8793-1518","authenticated-orcid":false,"given":"Rui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-7024","authenticated-orcid":false,"given":"Jiesi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-7286","authenticated-orcid":false,"given":"Yonglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"5686_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215361","author":"NR Jog","year":"2019","unstructured":"Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA (2019) Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215361","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"5686_CR2","doi-asserted-by":"publisher","first-page":"eabn4776","DOI":"10.1126\/sciadv.abn4776","volume":"8","author":"BA Mart\u00ednez","year":"2022","unstructured":"Mart\u00ednez BA, Shrotri S, Kingsmore KM, Bachali P, Grammer AC, Lipsky PE (2022) Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases. Sci Adv 8(17):eabn4776. https:\/\/doi.org\/10.1126\/sciadv.abn4776","journal-title":"Sci Adv"},{"issue":"3","key":"5686_CR3","doi-asserted-by":"publisher","first-page":"CD007478","DOI":"10.1002\/14651858","volume":"3","author":"CW Hannon","year":"2021","unstructured":"Hannon CW, McCourt C, Lima HC, Chen S, Bennett C (2021) Interventions for cutaneous disease in systemic lupus erythematosus. Cochrane Database Syst Rev 3(3):CD007478. https:\/\/doi.org\/10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"key":"5686_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102331","volume":"106","author":"SJ Sung","year":"2020","unstructured":"Sung SJ, Fu SM (2020) Interactions among glomerulus infiltrating macrophages and intrinsic cells via cytokines in chronic lupus glomerulonephritis. J Autoimmun 106:102331. https:\/\/doi.org\/10.1016\/j.jaut.2019.102331","journal-title":"J Autoimmun"},{"issue":"8","key":"5686_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-020-00236-x","volume":"28","author":"JI Gamez-Nava","year":"2020","unstructured":"Gamez-Nava JI, Diaz-Rizo V, Perez-Guerrero EE, Mu\u00f1oz-Valle JF, Salda\u00f1a-Cruz AM, Fajardo-Robledo NS, Jacobo-Cuevas H, Nava-Valdivia CA, Alcaraz-Lopez MF, Trujillo X, Huerta M, Cardona-Mu\u00f1oz EG, Gonzalez-Lopez L (2020) Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study. Biomark Res 28(8):55. https:\/\/doi.org\/10.1186\/s40364-020-00236-x","journal-title":"Biomark Res"},{"issue":"1","key":"5686_CR6","doi-asserted-by":"publisher","first-page":"e147334","DOI":"10.1172\/JCI147334","volume":"132","author":"SA Chalmers","year":"2022","unstructured":"Chalmers SA, Ayilam Ramachandran R, Garcia SJ, Der E, Herlitz L, Ampudia J, Chu D, Jordan N, Zhang T, Parodis I, Gunnarsson I, Ding H, Shen N, Petri M, Mok CC, Saxena R, Polu KR, Connelly S, Ng CT, Mohan C, Putterman C (2022) The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. J Clin Investig 132(1):e147334. https:\/\/doi.org\/10.1172\/JCI147334","journal-title":"J Clin Investig"},{"issue":"6","key":"5686_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/ar3528","volume":"13","author":"TK Nowling","year":"2011","unstructured":"Nowling TK, Gilkeson GS (2011) Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 13(6):250. https:\/\/doi.org\/10.1186\/ar3528","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5686_CR8","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/j.1756-185X.2011.01657","volume":"15","author":"M Rodenas","year":"2012","unstructured":"Rodenas M, Kumar S, Freund KB, Moallem J (2012) Retinitis preceding systemic lupus erythematosus in absence of anti-phospholipid antibodies. Int J Rheum Dis 15(2):e28-30. https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01657","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5686_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40620-016-0273-x","volume":"29","author":"E Nerini","year":"2016","unstructured":"Nerini E, Bruno F, Citterio F, Schena FP (2016) Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? J Nephrol 29(5):627\u2013636. https:\/\/doi.org\/10.1007\/s40620-016-0273-x","journal-title":"J Nephrol"},{"issue":"28","key":"5686_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016420","volume":"98","author":"HS Choi","year":"2019","unstructured":"Choi HS, Han KD, Jung JH, Kim CS, Bae EH, Ma SK, Kim SW (2019) The risk of end-stage renal disease in systemic lupus erythematosus: a nationwide population-based study in Korea. Medicine (Baltimore) 98(28):e16420. https:\/\/doi.org\/10.1097\/MD.0000000000016420","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"5686_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00296-023-05409-z","volume":"44","author":"C Lao","year":"2024","unstructured":"Lao C, Van Dantzig P, White D, Rabindranath K, Foxall D, Lawrenson R (2024) Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematous: a population-based study. Rheumatol Int 44(3):469\u2013475. https:\/\/doi.org\/10.1007\/s00296-023-05409-z","journal-title":"Rheumatol Int"},{"issue":"1","key":"5686_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12882-020-01915-5","volume":"21","author":"SS Ahn","year":"2020","unstructured":"Ahn SS, Yoo J, Jung SM, Song JJ, Park YB, Lee SW (2020) Comparison of clinical features and outcomes between patients with early and delayed lupus nephritis. BMC Nephrol 21(1):258. https:\/\/doi.org\/10.1186\/s12882-020-01915-5","journal-title":"BMC Nephrol"},{"issue":"3","key":"5686_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/acr.22685","volume":"68","author":"L Plantinga","year":"2016","unstructured":"Plantinga L, Lim SS, Patzer R, McClellan W, Kramer M, Klein M, Pastan S, Gordon C, Helmick C, Drenkard C (2016) Incidence of end-stage renal disease among newly diagnosed systemic lupus erythematosus patients: the georgia lupus registry. Arthritis Care Res (Hoboken) 68(3):357\u2013365. https:\/\/doi.org\/10.1002\/acr.22685","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"5686_CR14","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1038\/s41598-018-24529-2","volume":"8","author":"MY Jiang","year":"2018","unstructured":"Jiang MY, Hwang JC, Feng IJ (2018) Impact of diabetes mellitus on the risk of end-stage renal disease in patients with systemic lupus erythematosus. Sci Rep 8(1):6008. https:\/\/doi.org\/10.1038\/s41598-018-24529-2","journal-title":"Sci Rep"},{"issue":"9","key":"5686_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"5686_CR16","doi-asserted-by":"publisher","unstructured":"Levin A, Agarwal R, Herrington WG, Heerspink HL, Mann JFE, Shahinfar S, Tuttle KR, Donner JA, Jha V, Nangaku M, de Zeeuw D, Jardine MJ, Mahaffey KW, Thompson AM, Beaucage M, Chong K, Roberts GV, Sunwold D, Vorster H, Warren M, Damster S, Malik C, Perkovic V, Participant Authors of the International Society of Nephrology\u2019s 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials (2020) International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int 98(4):849\u2013859. https:\/\/doi.org\/10.1016\/j.kint.2020.07.013(PMID: 32998816)","DOI":"10.1016\/j.kint.2020.07.013"},{"issue":"1","key":"5686_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12882-019-1475-y","volume":"20","author":"J Xiaoyan","year":"2019","unstructured":"Xiaoyan J, Rongyi C, Xuesen C, Jianzhou Z, Jun J, Xiaoqiang D, Xiaofang Y (2019) The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality. BMC Nephrol 20(1):301. https:\/\/doi.org\/10.1186\/s12882-019-1475-y","journal-title":"BMC Nephrol"},{"issue":"14","key":"5686_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12979-017-0096-1","volume":"19","author":"L Huang","year":"2017","unstructured":"Huang L, Litjens NHR, Kannegieter NM, Klepper M, Baan CC, Betjes MGH (2017) pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients. Immun Ageing 19(14):14. https:\/\/doi.org\/10.1186\/s12979-017-0096-1","journal-title":"Immun Ageing"},{"issue":"10","key":"5686_CR19","doi-asserted-by":"publisher","first-page":"e003665","DOI":"10.1161\/JAHA.116.003665","volume":"5","author":"AD Sniderman","year":"2016","unstructured":"Sniderman AD, Islam S, McQueen M, Pencina M, Furberg CD, Thanassoulis G, Yusuf S (2016) Age and cardiovascular risk attributable to apolipoprotein B, low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol. J Am Heart Assoc 5(10):e003665. https:\/\/doi.org\/10.1161\/JAHA.116.003665","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"5686_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/0886022X","volume":"42","author":"WB Zhao","year":"2020","unstructured":"Zhao WB, Zhu L, Rahman T (2020) Increased serum concentration of apolipoprotein B is associated with an increased risk of reaching renal replacement therapy in patients with diabetic kidney disease. Ren Fail 42(1):323\u2013328. https:\/\/doi.org\/10.1080\/0886022X","journal-title":"Ren Fail"},{"issue":"6","key":"5686_CR21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00125-006-0217-4","volume":"49","author":"S Braschi","year":"2006","unstructured":"Braschi S, Geoffrion M, Nguyen A, Gaudreau Y, Milne RW (2006) The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients. Diabetologia 49(6):1394\u20131401. https:\/\/doi.org\/10.1007\/s00125-006-0217-4","journal-title":"Diabetologia"},{"issue":"1","key":"5686_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12882-021-02632-3","volume":"23","author":"Z Li","year":"2022","unstructured":"Li Z, Han Q, Ye H, Li J, Wei X, Zhang R, Huang Q, Xu Y, Liu G, Li B, Yang Q (2022) Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy. BMC Nephrol 23(1):78. https:\/\/doi.org\/10.1186\/s12882-021-02632-3","journal-title":"BMC Nephrol"},{"issue":"2","key":"5686_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000444900","volume":"2","author":"Y Long","year":"2016","unstructured":"Long Y, Nie J (2016) Homocysteine in renal injury kidney. Disease (Basel) 2(2):80\u201387. https:\/\/doi.org\/10.1159\/000444900","journal-title":"Disease (Basel)"},{"key":"5686_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.redox.2018.09.021","volume":"20","author":"X Wu","year":"2019","unstructured":"Wu X, Zhang L, Miao Y, Yang J, Wang X, Wang CC, Feng J, Wang L (2019) Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol 20:46\u201359. https:\/\/doi.org\/10.1016\/j.redox.2018.09.021","journal-title":"Redox Biol"},{"issue":"1","key":"5686_CR25","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/s41467-022-34248-y","volume":"13","author":"X Fu","year":"2022","unstructured":"Fu X, Yu X, Jiang J, Yang J, Chen L, Yang Z, Yu C (2022) Small molecule-assisted assembly of multifunctional ceria nanozymes for synergistic treatment of atherosclerosis. Nat Commun 13(1):6528. https:\/\/doi.org\/10.1038\/s41467-022-34248-y","journal-title":"Nat Commun"},{"issue":"12","key":"5686_CR26","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1515\/CCLM.2007.347","volume":"45","author":"AM Gori","year":"2007","unstructured":"Gori AM, Sofi F, Marcucci R, Giusti B, Franco Gensini G, Abbate R (2007) Association between homocysteine, vitamin B(6) concentrations and inflammation. Clin Chem Lab Med 45(12):1728\u20131736. https:\/\/doi.org\/10.1515\/CCLM.2007.347","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"5686_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/toxres\/tfab020","volume":"10","author":"R Wang","year":"2021","unstructured":"Wang R, Han ZJ, Song G, Cui Y, Xia HF, Ma X (2021) Homocysteine-induced neural tube defects in chick embryos via oxidative stress and DNA methylation associated transcriptional down-regulation of miR-124. Toxicol Res (Camb) 10(3):425\u2013435. https:\/\/doi.org\/10.1093\/toxres\/tfab020","journal-title":"Toxicol Res (Camb)"},{"issue":"5","key":"5686_CR28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1681\/ASN.2008070730","volume":"20","author":"SI Hallan","year":"2009","unstructured":"Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR (2009) Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20(5):1069\u20131077. https:\/\/doi.org\/10.1681\/ASN.2008070730","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5686_CR29","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2337\/dc13-2036","volume":"37","author":"G Andr\u00e9sd\u00f3ttir","year":"2014","unstructured":"Andr\u00e9sd\u00f3ttir G, Jensen ML, Carstensen B, Parving HH, Rossing K, Hansen TW, Rossing P (2014) Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors. Diabetes Care 37(6):1660\u20131667. https:\/\/doi.org\/10.2337\/dc13-2036","journal-title":"Diabetes Care"},{"issue":"11","key":"5686_CR30","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/rheumatology\/keaa103","volume":"59","author":"F Farinha","year":"2020","unstructured":"Farinha F, Pepper RJ, Oliveira DG, McDonnell T, Isenberg DA, Rahman A (2020) Outcomes of membranous and proliferative lupus nephritis\u2014analysis of a single-centre cohort with more than 30 years of follow-up. Rheumatology (Oxford) 59(11):3314\u20133323. https:\/\/doi.org\/10.1093\/rheumatology\/keaa103","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5686_CR31","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1136\/lupus-2015-000144","volume":"3","author":"EM Williams","year":"2016","unstructured":"Williams EM, Bruner L, Adkins A, Vrana C, Logan A, Kamen D, Oates JC (2016) I too, am America: a review of research on systemic lupus erythematosus in African-Americans. Lupus Sci Med 3(1):e000144. https:\/\/doi.org\/10.1136\/lupus-2015-000144","journal-title":"Lupus Sci Med"},{"issue":"4","key":"5686_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5414\/CN109305","volume":"90","author":"X Huang","year":"2018","unstructured":"Huang X, Tang Z, Wu X, Zhang L, Fan W, Zhang H, Hu W, Liu Z (2018) Long-term renal outcomes and related risk factors of familial systemic lupus erythematosus patients with lupus nephritis. Clin Nephrol 90(4):262\u2013269. https:\/\/doi.org\/10.5414\/CN109305","journal-title":"Clin Nephrol"},{"issue":"1","key":"5686_CR33","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41598-021-81664-z","volume":"11","author":"R Wang","year":"2021","unstructured":"Wang R, An D, Wu Y, Ma P, Guo Y, Tang L (2021) Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study. Sci Rep 11(1):2002. https:\/\/doi.org\/10.1038\/s41598-021-81664-z","journal-title":"Sci Rep"},{"issue":"1","key":"5686_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13018-023-03536-8","volume":"18","author":"H Wang","year":"2023","unstructured":"Wang H, Yan C, Wu Q, Zeng H, Zhang Z, Wang W, Sun X (2023) Acute gout attacks during the perioperative period and risk factors of recurrence after orthopedic surgery among untreated gout patients. J Orthop Surg Res 18(1):61. https:\/\/doi.org\/10.1186\/s13018-023-03536-8","journal-title":"J Orthop Surg Res"},{"issue":"8","key":"5686_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/jcm8081202","volume":"8","author":"KM Chiang","year":"2019","unstructured":"Chiang KM, Tsay YC, Vincent Ng TC, Yang HC, Huang YT, Chen CH, Pan WH (2019) Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in Han Chinese? J Clin Med 8(8):1202. https:\/\/doi.org\/10.3390\/jcm8081202","journal-title":"J Clin Med"},{"issue":"6","key":"5686_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10157-009-0237-8","volume":"13","author":"Japanese Society of Nephrology","year":"2009","unstructured":"Japanese Society of Nephrology (2009) Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol 13(6):537\u2013566. https:\/\/doi.org\/10.1007\/s10157-009-0237-8","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"5686_CR37","doi-asserted-by":"publisher","first-page":"15242","DOI":"10.1038\/srep15242","volume":"16","author":"H You-Hsien Lin","year":"2015","unstructured":"You-Hsien Lin H, Yen CY, Lim LM, Hwang DY, Tsai JC, Hwang SJ, Hung CC, Chen HC (2015) Microscopic haematuria and clinical outcomes in patients with stage 3\u20135 nondiabetic chronic kidney disease. Sci Rep 16(5):15242. https:\/\/doi.org\/10.1038\/srep15242","journal-title":"Sci Rep"},{"issue":"11","key":"5686_CR38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s00125-017-4401-5","volume":"60","author":"G Botteri","year":"2017","unstructured":"Botteri G, Montori M, Gum\u00e0 A, Pizarro J, Ced\u00f3 L, Escol\u00e0-Gil JC, Li D, Barroso E, Palomer X, Kohan AB, V\u00e1zquez-Carrera M (2017) VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells. Diabetologia 60(11):2262\u20132273. https:\/\/doi.org\/10.1007\/s00125-017-4401-5","journal-title":"Diabetologia"},{"issue":"5","key":"5686_CR39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s11255-012-0376-9","volume":"45","author":"OE Ayodele","year":"2013","unstructured":"Ayodele OE, Okpechi IG, Swanepoel CR (2013) Long-term renal outcome and complications in South Africans with proliferative lupus nephritis. Int Urol Nephrol 45(5):1289\u20131300. https:\/\/doi.org\/10.1007\/s11255-012-0376-9","journal-title":"Int Urol Nephrol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05686-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T02:06:00Z","timestamp":1726193160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05686-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5686"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05686-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they have no known competing financial interests or personal relationships that could have influenced the research presented in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}